Thursday, January 18, 2024 4:44:37 AM
1/16/2024
GREENVILLE, S.C. (WLOS) — An individualized treatment for cancer?
King is one of three patients participating in a basket trial designated for solid tumor cancers. The FDA defines a basket trial as a drug studied across multiple cancer populations. [[ King is being treated for Ovarian ]]
The other patients, from Wisconsin and California, have brain and breast cancer, respectively.
King's involvement in the basket trial is one of happenstance.
Riley Polk is president of Orbis Health Solutions, the biotechnology company behind the vaccine King is receiving.
THE NEXT BIG ADVANCE IN CANCER TREATMENT COULD BE A VACCINE
In 2017, Polk's 18-year-old daughter Carson and King were being treated at the same cancer facility.
Orbis founder Dr. Tom Wagner had spent the previous two decades developing cancer immunotherapies specifically for melanoma, but they were getting ready to expand the study.
“At the time, they were thinking we’re just going to get into ovarian cancer vaccines, and that’s when we all just went, 'Please keep Catie in mind when you get to that point.' And so now it’s great that it’s not just ovarian, it’s any kind,” Catie's mom Leslie Green said. “It’s any solid tissue.”
more
https://wlos.com/news/local/were-making-history-asheville-native-being-treated-with-promising-cancer-vaccine
'Cancer will be cured,' scientist behind immunotherapy treatment explains how
1/17/2024
https://wlos.com/news/local/cancer-will-be-cured-scientist-behind-immunotherapy-treatment-explains-how-orbis-health-solutions-dr-tom-wagner-sloan-kettering-institute
Orbis Health Solutions
https://www.orbishealthsolutions.com/
Recent NWBO News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
FEATURED Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • May 17, 2024 11:00 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM